How to identify older cancer patients who should benefit from comprehensive geriatric assessment?
✍ Scribed by Luce⁎, S.; De Breucker, S.; Van Gossum, Au.; Demols, A.; Mekinda, Z.; Ena, G.; Maerevoet, M.; Bailly, B.; Roumeguère, T.; Ghanooni, R.; Nouwynck, C.; Van Laethem, J.L.; Sokolow, Y.; Simon, P.; Bron, D.; Vervaet, C.; Marchand, M.; Pepersack, T.
- Book ID
- 122460444
- Publisher
- Elsevier
- Year
- 2012
- Tongue
- English
- Weight
- 74 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1879-4068
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND: The authors set out to analyze if a simple comprehensive geriatric assessment (CGA) could objectively identify elderly patients with diffuse large cell lymphoma (DLCL) who can be effectively treated with anthracycline‐containing immunochemotherapy. ## METHODS: CGA was
## Abstract ## BACKGROUND. Impairments in geriatric domains adversely affect health outcomes of the elderly. The Comprehensive Geriatric Assessment (CGA) is a key component of the treatment approach for older cancer patients, but it is time consuming. In this pilot study, the authors evaluated the